4//SEC Filing
Dunlap Charles L 4
Accession 0001000229-18-000060
CIK 0001000229other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 5:29 PM ET
Size
15.0 KB
Accession
0001000229-18-000060
Insider Transaction Report
Form 4
Dunlap Charles L
Director
Transactions
- Tax Payment
Common Shares
2018-03-31−8→ 4,062 total - Exercise/Conversion
Restricted Shares
2018-03-31−1,436→ 0 totalExercise: $0.00→ Common Shares (1,436 underlying) - Exercise/Conversion
Restricted Shares
2018-04-01−1,299→ 0 totalExercise: $0.00→ Common Shares (1,299 underlying) - Tax Payment
Common Shares
2018-04-01−7→ 5,354 total - Exercise/Conversion
Common Shares
2018-03-31+1,436→ 4,070 total - Exercise/Conversion
Common Shares
2018-04-01+1,299→ 5,361 total - Award
Restricted Shares
2018-04-01+1,387→ 1,387 totalExercise: $0.00→ Common Shares (1,387 underlying)
Footnotes (3)
- [F1]The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period ending April 1, 2019, subject to the terms of issuance.
- [F2]The Restricted Shares vested, without performance criteria, at the end of a three-year vesting period ending April 1, 2018, subject to the terms of issuance.
- [F3]The Restricted Shares vested, without performance criteria, at the end of a one-year vesting period ending April 1, 2018, subject to the terms of issuance.
Documents
Issuer
CORE LABORATORIES N V
CIK 0001000229
Entity typeother
Related Parties
1- filerCIK 0001437468
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 5:29 PM ET
- Size
- 15.0 KB